Concomitant TP53 mutation in early-stage resected EGFR-mutated non-small cell lung cancer: a narrative approach in a genetically admixed Brazilian cohort.

Braz J Med Biol Res · 2023 · PMC10085757 · PMID 37042869

Europe PMC DOI

hedged sentences

0.0570

closest p · 1.1× alpha

0.0790

boldest claim

The sentences

marginally significantP=0.057so close (0.05 < p ≤ 0.1)

We found a marginally significant difference in OS between genders (P=0.057) and between mutant and wild type TP53 (P=0.079).

also in 26,082 other papers

borderline significanceP=0.079so close (0.05 < p ≤ 0.1)

In univariate analysis, distant metastases (P=0.027), pathological stage (IIIA-IIIB vs I-II; P=0.028), and TP53 status (borderline significance between wild type and mutant; P=0.079) influenced OS.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.